Levade T - Search Results

1

Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833.

Bezombes C, Maestre N, Laurent G, Levade T, Bettaïeb A, Jaffrézou JP. Bezombes C, et al. Among authors: levade t. FASEB J. 1998 Jan;12(1):101-9. doi: 10.1096/fasebj.12.1.101. FASEB J. 1998. PMID: 9438415

2

Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizine.

Jaffrézou JP, Levade T, Chatelain P, Laurent G. Jaffrézou JP, et al. Among authors: levade t. Cancer Res. 1992 Dec 1;52(23):6440-6. Cancer Res. 1992. PMID: 1423291

3

In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.

Jaffrézou JP, Levade T, Thurneyssen O, Chiron M, Bordier C, Attal M, Chatelain P, Laurent G. Jaffrézou JP, et al. Among authors: levade t. Cancer Res. 1992 Mar 1;52(5):1352-9. Cancer Res. 1992. PMID: 1737397

4

Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein.

Jaffrézou JP, Herbert JM, Levade T, Gau MN, Chatelain P, Laurent G. Jaffrézou JP, et al. Among authors: levade t. J Biol Chem. 1991 Oct 15;266(29):19858-64. J Biol Chem. 1991. PMID: 1918089 Free article.

5

Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells.

Jaffrézou JP, Levade T, Kuhlein E, Thurneyssen O, Chiron M, Grandjean H, Carrière D, Laurent G. Jaffrézou JP, et al. Among authors: levade t. Cancer Res. 1990 Sep 1;50(17):5558-66. Cancer Res. 1990. PMID: 2386962

6

Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.

Levade T, Vidal F, Vermeersch S, Andrieu N, Gatt S, Salvayre R. Levade T, et al. Biochim Biophys Acta. 1995 Oct 5;1258(3):277-87. doi: 10.1016/0005-2760(95)00132-v. Biochim Biophys Acta. 1995. PMID: 7548198

7

Low temperatures and hypertonicity do not block cytokine-induced stimulation of the sphingomyelin pathway but inhibit nuclear factor-kappa B activation.

Andrieu N, Salvayre R, Jaffrézou JP, Levade T. Andrieu N, et al. Among authors: levade t. J Biol Chem. 1995 Oct 13;270(41):24518-24. doi: 10.1074/jbc.270.41.24518. J Biol Chem. 1995. PMID: 7592669 Free article.

8

Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance.

Jaffrézou JP, Chen KG, Durán GE, Muller C, Bordier C, Laurent G, Sikic BI, Levade T. Jaffrézou JP, et al. Among authors: levade t. Biochim Biophys Acta. 1995 Apr 6;1266(1):1-8. doi: 10.1016/0167-4889(94)00219-5. Biochim Biophys Acta. 1995. PMID: 7718613 Free article.

9

Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts.

Andrieu N, Salvayre R, Levade T. Andrieu N, et al. Among authors: levade t. Biochem J. 1994 Oct 15;303 ( Pt 2)(Pt 2):341-5. doi: 10.1042/bj3030341. Biochem J. 1994. PMID: 7980390 Free PMC article.

10

Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis.

Jaffrézou JP, Levade T, Bettaïeb A, Andrieu N, Bezombes C, Maestre N, Vermeersch S, Rousse A, Laurent G. Jaffrézou JP, et al. Among authors: levade t. EMBO J. 1996 May 15;15(10):2417-24. EMBO J. 1996. PMID: 8665849 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters